HMHegias Mira-Bontenbal

Hegias Mira-Bontenbal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hegias Mira-Bontenbal has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    X-chromosome upregulation operates on a gene-by-gene basis at RNA and protein levels

    by Ryan N. Allsop, Jeffrey Boeren, Beatrice F. Tan, Sarra Merzouk, Suresh Poovanthingal, Wilfred F. J. van Ijcken, Jeroen A. A. Demmers, Hegias Mira Bontenbal, Cristina Gontan, Joost Gribnau, et al.

    Gene dosage compensation mechanisms are crucial for mammalian development. In mice, recent findings show that cells can sense the number of X chromosomes. Loss or inactivation of one of the two X chromosomes is compensated by upregulating the remaining active X chromosome, a process termed X-chromosome upregulation (XCU). However, how cells sense X-chromosome dosage and induce XCU remains unclear. Here, we show that heterozygous X chromosome fragment deletions in mouse pluripotent stem cells induces XCU in trans, and that compensation takes place at the mRNA and protein level. Furthermore, we found that inducing gene silencing in cis on autosomes induces gene dosage compensation in trans. This work provides significant insights into the molecular foundations of mammalian gene dosage compensation.


  • Open Access

    HCFC1 and YY1 mediate recruitment of COMPASS and Integrator to initiate X chromosome inactivation

    by Jeffrey Boeren, Beatrice F. Tan, Sarra Merzouk, Eveline Rentmeester, Rien van Haperen, Samuel J. Luchsinger-Morcelle, Cheryl Maduro, Richelle Rietdijk, Büşra Göynük, Wilfred F.J. van Ijcken, et al.

    The evolution of mammalian sex chromosomes has driven the emergence of mechanisms that balance X-linked gene dosage between male (XY) and female (XX) cells. In females, dosage compensation is achieved through X chromosome inactivation (XCI), initiated by upregulation of the long non-coding RNA Xist , which spreads in cis , recruiting chromatin modifiers to silence gene expression on one X chromosome. Here, we conducted a forward genetic screen and identified X-encoded Host Cell Factor 1 (HCFC1), a member of the COMPASS H3K4 methyltransferase complex, as a dose-dependent XCI-activator. HCFC1 loss results in genome-wide reduction of H3K4me3 at specific regulatory elements and downregulation of nearby genes, including Xist . We show that HCFC1 and YY1 are co-recruited genome-wide to gene regulatory elements. Mass spectrometry analysis confirmed an interaction of HCFC1 and YY1 and uncovered the Integrator complex as another prominent YY1 partner. YY1 depletion results in genome-wide loss of Integrator recruitment at gene regulatory elements and reduced expression of nearby genes, including Xist cis -regulatory genes Jpx and Ftx . These results highlight a co-regulatory role for HCFC1 in COMPASS recruitment and Xist activation, alongside YY1-mediated recruitment of Integrator to Xist regulatory elements and genes to activate female-exclusive XCI.

  • Open Access

    MeCP2 binding and genome–lamina reorganization precede long gene activation during mouse corticogenesis

    by Pim M. J. Rullens, Sandra S. de Vries, Silke J. A. Lochs, Corina M. Markodimitraki, Keith M. Garner, Youri Adolfs, Hegias Mira-Bontenbal, Micha M. Müller, Elisa Bugani, Marvin E. Tanenbaum, et al.

    During corticogenesis, neural gene expression is tightly coordinated by chromatin and epigenetic changes, whose misregulation can lead to neurodevelopmental disorders 1–4 . The role of spatial genome organization—particularly interactions with the nuclear lamina—during these developmental programs remains poorly understood. Here, we combined in utero electroporation with scDam&T-seq to jointly profile genome–lamina contacts and transcriptomes in single cells of the mouse embryonic cortex. Interestingly, we find extensive genome–lamina reorganization during corticogenesis that is strongly biased towards long neuronal genes (≥100 kb), which are associated with neurodevelopmental disorders including autism spectrum disorder. Detachment of these genes frequently precedes transcriptional activation, positioning lamina disengagement as an early gene regulatory event. We identify the methyl CpG binding protein 2 (MeCP2)—mutated in Rett syndrome—as a candidate mediator of this process. MeCP2 binds lamina-associated, hydroxymethylated long genes before their repositioning, suggesting that MeCP2 may play a role in genome–lamina reorganization. These findings suggest a link between prevalent genome–lamina reorganization and MeCP2 regulation to ensure proper spatiotemporal activation of long neuronal genes during corticogenesis.


  • Open Access

    X-chromosome upregulation operates on a gene-by-gene basis at RNA and protein levels

    by Ryan N. Allsop, Jeffrey Boeren, Beatrice F. Tan, Sarra Merzouk, Suresh Poovanthingal, Wilfred F.J. van Ijcken, Jeroen A.A. Demmers, Hegias Mira Bontenbal, Cristina Gontan, Joost Gribnau, et al.

    Gene dosage compensation mechanisms are crucial for mammalian development. In mice, recent findings show that cells can sense the number of X chromosomes. Loss or inactivation of one of the two X chromosomes is compensated by upregulating the remaining active X chromosome, a process termed X-chromosome upregulation (XCU). However, how cells sense X-chromosome dosage and induce XCU remains unclear. Here, we show that heterozygous X chromosome fragment deletions in mouse pluripotent stem cells induces XCU in trans , and that compensation takes place at the mRNA and protein level. Furthermore, we found that inducing gene silencing in cis on autosomes induces gene dosage compensation in trans . This work provides significant insights into the molecular foundations of mammalian gene dosage compensation.


  • Open Access

    Orchestrating Asymmetric Expression: Mechanisms behind Xist Regulation

    by Samuel Jesus Luchsinger-Morcelle, Joost Gribnau, Hegias Mira-Bontenbal

    Compensation for the gene dosage disequilibrium between sex chromosomes in mammals is achieved in female cells by repressing one of its X chromosomes through a process called X chromosome inactivation (XCI), exemplifying the control of gene expression by epigenetic mechanisms. A critical player in this mechanism is Xist, a long, non-coding RNA upregulated from a single X chromosome during early embryonic development in female cells. Over the past few decades, many factors involved at different levels in the regulation of Xist have been discovered. In this review, we hierarchically describe and analyze the different layers of Xist regulation operating concurrently and intricately interacting with each other to achieve asymmetric and monoallelic upregulation of Xist in murine female cells. We categorize these into five different classes: DNA elements, transcription factors, other regulatory proteins, long non-coding RNAs, and the chromatin and topological landscape surrounding Xist.


  • Open Access

    Genetic and epigenetic determinants of reactivation of Mecp2 and the inactive X chromosome in neural stem cells

    by H. Mira-Bontenbal, B. Tan, C. Gontan, S. Goossens, R.G. Boers, J.B. Boers, C. Dupont, M.E. van Royen, W.F.J. Ijcken, P. French, et al.


  • Open Access

    Genetic and epigenetic determinants of reactivation of Mecp2 and the inactive X chromosome in neural stem cells

    by Hegias Mira-Bontenbal, Beatrice Tan, Cristina Gontan, Sander Goossens, R.G. Boers, J. Boers, Catherine Dupont, Martin van Royen, Wilfred van Ijcken, Pim French, et al.

    Rett Syndrome is a neurodevelopmental disorder in girls that is caused by heterozygous inactivation of the chromatin remodeler gene MECP2 . Rett Syndrome may therefore be treated by reactivation of the wild type copy of MECP2 from the inactive X chromosome. Most studies that model Mecp2 reactivation have used mouse fibroblasts rather than neural cells, which would be critical for phenotypic reversal, and rely on fluorescent reporters that lack adequate sensitivity. Here, we present a mouse model system for monitoring Mecp2 reactivation that is more sensitive and versatile than any bioluminescent and fluorescent system currently available. The model consists of neural stem cells derived from female mice with a dual reporter system where MECP2 is fused to NanoLuciferase and TdTomato on the inactive X chromosome. We show by bioluminescence and fluorescence that Mecp2 is synergistically reactivated by 5-Aza treatment and Xist knockdown. As expected, other genes on the inactive X chromosome are also reactivated, the majority of which overlaps with genes reactivated early during reprogramming of mouse embryonic fibroblasts to iPSCs. Genetic and epigenetic features such as CpG density, SINE elements, distance to escapees and CTCF binding are consistent indicators of reactivation, whereas different higher order chromatin areas are either particularly prone or resistant to reactivation. Our MeCP2 reactivation monitoring system thereby suggests that genetic and epigenetic features on the inactive X chromosome affect reactivation of its genes, irrespective of cell type or procedure of reactivation.

  • New Xist-Interacting Proteins in X-Chromosome Inactivation

    by Hegias Mira-Bontenbal, Joost Gribnau